Intrinsic Value of S&P & Nasdaq Contact Us

Labcorp Holdings Inc. LH NYSE

NYSE • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
58/100
2/7 Pass
SharesGrow Intrinsic Value
$367.74
+36.8%
Analyst Price Target
$321.33
+19.5%

Labcorp Holdings Inc. (LH) generated $1.64B in operating cash flow for fiscal year 2025. After capital expenditures of $434.5M, free cash flow was $1.21B.

Free cash flow margin was 8.6% of revenue. Cash conversion ratio was 1.87x, indicating earnings are backed by cash.

The company returned $240.7M in dividends and $450M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (54/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (45/100) — Cash conversion ratio was 1.87x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 58/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
58/100
SG Score
View full scorecard →
VALUE
36/100
Price-to-Earnings & upside
→ Valuation
FUTURE
79/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
54/100
Proven by this page
~
GROWTH
40/100
→ Income
~
INCOME
45/100
→ Income
Labcorp Holdings Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $1.64B$1.64B$1.59B$1.33B$1.96B
Capital Expenditure $-434.5M$-434.5M$-489.9M$-453.6M$-481.9M
Free Cash Flow $1.21B$1.21B$1.1B$874.1M$1.47B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message